Guided biofilm therapy for the treatment of peri-implant diseases
Ana Molina Villar
Guided biofilm therapy for the treatment of peri-implant diseases
Ana Molina Villar
LEARNING
objectives
Guided Biofilm Therapy for the treatment of peri-implant diseases
Peri-implant diseases are plaque-associated pathologic conditions around dental implants, characterized by inflammation of the peri-implant mucosa in the case of peri-implant mucositis, and inflammation with subsequent progressive loss of supporting bone in the case of peri-implantitis. Its prevalence is very high, with mucositis affecting around 80 percent of subjects with dental implants, and peri-implantitis affecting between 28-56 percent of patients, according to the different studies.
The therapy for the treatment of peri-implant diseases is aimed to reduce the inflammatory component and to arrest disease progression. The goal of anti-infective therapies is to eliminate the biofilm surrounding the implant and prosthetic structures, however, both the micro (surface characteristics) and macro design (implant design, position, supracrestal components, prostheses design, etc.) of the implant-supported restorations may impair the adequate debridement of the peri-implant tissues with conventional methods.
New technologies such as the use of prophylaxis powder have proven to be highly effective for the removal of biofilm around dental implants and the control of peri-implant inflammation, without damaging neither the soft tissues nor the implant components.
Get your CE points and register now for free!
Release date: Friday 26th April, 2019, 12:00 PM
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Tribune Group designates this activity for 1 continuing education credits.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
CE QUIZ
Please login and watch the entire webinar before attempting to take the C.E. Quiz. Once you watch the webinar please return here to take the C.E. Quiz and print your C.E. Certificate.
Already logged in and watched the webinar? Please try to reload the page by using the button below.
Having trouble accessing the quiz? Please read the frequently asked questions or contact our support team. You can also email us at support@swissdentalacademyonline.com
SPEAKER
DETAILS
Ana Molina Villar
Dr. Ana Molina graduated in Dentistry at Complutense University in Madrid, where later on she obtained her Master in Periodontology ad Implant Dentistry and the Board in Periodontology by the European Federation of Periodontology.
She has a Master in Dental Sciences and is currently doing her PhD in the field of Periodontal Medicine, studying the relationship betwen cardiovascular disease and periodontitis. She belongs to the research group “Etiology and therapy of periodontal diseases”, lead by Prof. Dr. Mariano Sanz in Madrid.
She combines her private practice in Periodontology and Implant Dentistry with her teaching activity as Assistant Professor of Periodontology at the undergraduate and postgraduate programs at Complutense University in Madrid.
Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Tribune Group GmbH and Dental Tribune International GmbH.
© 2018